August 2021
From the NewsVadadustat for Anemia in Patients with Chronic Kidney Disease
Anemia is a common complication of chronic kidney disease (CKD) and is associated with a ...
Dose Smarter
Deliver AI-powered personalized dosing recommendations for your patients.
Why Personalized Dosing?
Unlike conventional dosing approaches which assume each patient is an average drug responder, the Dosis platform leverages artificial intelligence and control algorithms to determine a patient’s unique response to a medication and deliver optimal dose recommendations.
Increase Dose Efficiency
Use less drug to achieve equivalent or improved patient outcomes. An increase in dose efficiency means lowered drug exposure for patients and lowered costs for clinics.
Decrease Risk of Adverse Events
Decrease the likelihood of serious adverse events by decreasing patient exposure to drugs. Higher doses are associated with a higher likelihood of adverse events.
The Dosis Platform
Dosis is a cloud-based clinical decision support platform that uses artificial intelligence and control algorithms to personalize drug dosing.
Precise Recommendations
Generates personalized recommendations to keep patients within a specified therapeutic range
Increased Dose Efficiency
Empowers clinicians to use dramatically less medication to achieve the same or better patient outcomes
Proven Track Record
Used in clinics across the United States, and backed by years of peer-reviewed research
Strategic Anemia Advisor
Used in over 15 million treatments, SAA personalizes drug dosing for erythropoiesis-stimulating agents (ESAs), a class of drugs used to treat dialysis patients with chronic anemia.
Our Clinics See Results
Clinics that use SAA achieve equivalent or improved hemoglobin outcomes while using dramatically less drug, resulting in reduced patient drug exposure and reduced drug cost.
Pricing
We earn when you save. Our pricing model is built on aligned incentives, and we only charge a portion of the savings you realize.
Recent News
August 2021
From the NewsOne in two pregnancies are affected by iron deficiency, yet many women don’t get a simple screening test to check
Half of pregnant women who had a simple blood test to check their iron stores ...
August 2021
From the NewsTrials reveal efficacy and safety of oral drug for treating anemia associated with kidney disease
Pooled results from phase 3 clinical trials demonstrate that roxadustat is efficacious and may be ...